Exploring the associations between drug side-effects and therapeutic indications

Journal of Biomedical Informatics

Volumn 51, Issue , 2014, Pages 15-23

  Wang, Fei ^a   Zhang, Ping ^a   Cao, Nan ^a   Hu, Jianying ^a   Sorrentino, Robert ^a  

^a IBM T J WATSON RESEARCH CENTER   (United States)

Author keywords

Associations; Side effects; Theraputic indications

Indexed keywords

ASSOCIATION REACTIONS; FORECASTING; PATIENT TREATMENT; PROTEINS; STRUCTURE (COMPOSITION); USER INTERFACES;

10-FOLD CROSS-VALIDATION; DRUG SIDE EFFECTS; HIGHLY-CORRELATED; INFORMATION SOURCES; PREDICTION PERFORMANCE; PREDICTIVE INFORMATION; SIDE EFFECT; THERAPUTIC INDICATIONS;

DRUG INTERACTIONS;

DONEPEZIL; FLUOXETINE; RIVASTIGMINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TACRINE; DRUG; PROTEIN;

ADVERSE DRUG REACTION; APNEA; ARTICLE; BLINDNESS; CLAUDICATION; DRUG INDICATION; DRUG INFORMATION; DRUG SAFETY; DRUG STRUCTURE; DRUG TARGETING; FAINTNESS; GOUT; HALLUCINATION; HEART BLOCK; HEART FAILURE; HEART VENTRICLE EXTRASYSTOLE; HYPERTENSION; HYPERURICEMIA; IMPOTENCE; MEMORY DISORDER; ORTHOSTATIC HYPOTENSION; PAIN; PEMPHIGUS; PHENOTYPE; PREDICTION; SENSITIVITY AND SPECIFICITY; SOMNOLENCE; TACHYCARDIA; TINNITUS; URINE RETENTION; VERTIGO; WEAKNESS; WEIGHT REDUCTION; CHEMISTRY; CLASSIFICATION; DATA MINING; DRUG DATABASE; DRUG REPOSITIONING; DRUG SURVEILLANCE PROGRAM; DRUG THERAPY; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; HUMAN; ORGANIZATION AND MANAGEMENT; PROCEDURES; PROTEIN ANALYSIS;

ADVERSE DRUG REACTION REPORTING SYSTEMS; DATA MINING; DATABASES, PHARMACEUTICAL; DRUG REPOSITIONING; DRUG THERAPY; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; HUMANS; PHARMACEUTICAL PREPARATIONS; PROTEIN INTERACTION MAPPING; PROTEINS;

EID: 84908030483     PISSN: 15320464     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbi.2014.03.014     Document Type: Article

References (33)

1. DiMasi J.A., Hansen R.W., Grabowski H.G. The price of innovation: new estimates of drug development costs. J Health Econ 2003, 22:151-185.
2. Hopkins A.L. Network pharmacology: the next paradigm in drug discovery. Nat Chem Biol 2008, 4:682-690.
3. Chiang A.P., Butte A.J. Systematic evaluation of drug-disease relationships to identify leads for novel drug uses. Clin Pharmacol Therapeut 2009, 86:507-510.
4. Keiser M.J., Setola V., Irwin J.J., Laggner C., Abbas A.I., Hufeisen S.J., et al. Predicting new molecular targets for known drugs. Nature 2009, 462:175-181.
5. Li J., Zhu X., Chen J.Y. Building disease-specific drug-protein connectivity maps from molecular interaction networks and pubmed abstracts. PLoS Comput Biol 2009, 5:e1000450.
6. Kotelnikova E., Yuryev A., Mazo I., Daraselia N. Computational approaches for drug repositioning and combination therapy design. J Bioinform Comput Biol 2010, 8:593-606.
7. Campillos M., Kuhn M., Gavin A.-C., Jensen L.J., Bork P. Drug target identification using side-effect similarity. Science 2008, 321:263-266.
8. Yang L., Agarwal P. Systematic drug repositioning based on clinical side-effects. PloS One 2011, 6:e28025.
9. Hu G., Agarwal P. Human disease-drug network based on genomic expression profiles. PLoS One 2009, 4. e6536.
10. Sirota M., Dudley J.T., Kim J., Chiang A.P., Morgan A.A., Sweet-Cordero A., et al. Discovery and preclinical validation of drug indications using compendia of public gene expression data. Sci Translat Med 2011, 3. 96ra77.
11. Gottlieb A., Stein G.Y., Ruppin E., Sharan R. Predict: a method for inferring novel drug indications with application to personalized medicine. Mol Syst Biol 2011, 7.
12. Li J, Lu Z. A new method for computational drug repositioning using drug pairwise similarity. In: 2012 IEEE international conference on bioinformatics and biomedicine (BIBM), IEEE; 2012. p. 1-4.
13. Zhang P., Agarwal P., Obradovic Z. Computational drug repositioning by ranking and integrating multiple data sources. Machine learning and knowledge discovery in databases 2013, 579-594. Springer.
14. Giacomini K.M., Krauss R.M., Roden D.M., Eichelbaum M., Hayden M.R., Nakamura Y. When good drugs go bad. Nature 2007, 446:975-977.
15. Atias N., Sharan R. An algorithmic framework for predicting side effects of drugs. J Comput Biol 2011, 18:207-218.
16. Pauwels E., Stoven V., Yamanishi Y. Predicting drug side-effect profiles: a chemical fragment-based approach. BMC Bioinform 2011, 12:169.
17. Scheiber J., Jenkins J.L., Sukuru S.C.K., Bender A., Mikhailov D., Milik M., et al. Mapping adverse drug reactions in chemical space. J Med Chem 2009, 52:3103-3107.
18. Scheiber J., Chen B., Milik M., Sukuru S.C.K., Bender A., Mikhailov D., et al. Gaining insight into off-target mediated effects of drug candidates with a comprehensive systems chemical biology analysis. J Chem Inform Model 2009, 49:308-317.
19. Xie L., Li J., Xie L., Bourne P.E. Drug discovery using chemical systems biology: identification of the protein-ligand binding network to explain the side effects of cetp inhibitors. PLoS Comput Biol 2009, 5:e1000387.
20. Yamanishi Y., Pauwels E., Kotera M. Drug side-effect prediction based on the integration of chemical and biological spaces. J Chem Inform Model 2012, 52:3284-3292.
21. Huang L.-C., Wu X., Chen J.Y. Predicting adverse drug reaction profiles by integrating protein interaction networks with drug structures. Proteomics 2013, 13:313-324.
22. Liu M., Wu Y., Chen Y., Sun J., Zhao Z., Chen X.-W., et al. Large-scale prediction of adverse drug reactions using chemical, biological, and phenotypic properties of drugs. J Am Med Inform Assoc 2012, 19:e28-e35.
23. Upton G.J. Fisher's exact test. J Roy Stat Soc. Ser A (Stat Soc) 1992, 395-402.
24. Zhang P, Wang F, Hu J, Sorrentino R. Exploring the relationship between drug side-effects and therapeutic indications. In: Proceedings of Annual Symposium of American Medical Informatics Association (AMIA); 2013 p. 1568-1577.
25. Wishart D.S., Knox C., Guo A.C., Cheng D., Shrivastava S., Tzur D., et al. Drug actions and drug targets. Nucl Acids Res 2008, 36:D901-D906.
26. Wang Y., Xiao J., Suzek T.O., Zhang J., Wang J., Bryant S.H. Pubchem: a public information system for analyzing bioactivities of small molecules. Nucl Acids Res 2009, 37:W623-W633.
27. Apweiler R., Bairoch A., Wu C.H., Barker W.C., Boeckmann B., Ferro S., et al. Uniprot: the universal protein knowledgebase. Nucl Acids Res 2004, 32:D115-D119.
28. Kuhn M., Campillos M., Letunic I., Jensen L.J., Bork P. A side effect resource to capture phenotypic effects of drugs. Mol Syst Biol 2010, 6.
29. Bodenreider O. The unified medical language system (umls): integrating biomedical terminology. Nucl Acids Res 2004, 32:D267-D270.
30. Pedregosa F., Varoquaux G., Gramfort A., Michel V., Thirion B., Grisel O., et al. Scikit-learn: machine learning in python. J Mach Learn Res 2011, 12:2825-2830.
31. Lasko T.A., Bhagwat J.G., Zou K.H., Ohno-Machado L. The use of receiver operating characteristic curves in biomedical informatics. J Biomed Inform 2005, 38:404-415.
32. Kamada T., Kawai S. An algorithm for drawing general undirected graphs. Inform Process Lett 1989, 31:7-15.
33. Cao N, Liu S, Tan L, Zhou X. Interactive poster: context-preserving dynamic graph visualization. In: IEEE symposium on information visualization; 2008.